UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
'OliX to target global market with RNA technology'
OliX Pharmaceutical’s RNAi (RNA interference) technology is getting the not...
by Lee Han-soo
|
2019-03-15 11:44
라인
SK Chemicals executive arrested for destroying evidence in humidifier sterilizers case
A high-ranking official at SK Chemicals has been arrested for trying to cov...
by Jeong Sae-im
|
2019-03-15 11:41
라인
[Special] Female doctors suffer discrimination from moment of selecting medical residents
The medical community was not an exception to sexual discrimination. Four o...
by Song Soo-youn
|
2019-03-15 10:24
라인
Idiopathic REM sleep behavior disorder raises risk of dementia, Parkinson’s
Researchers have discovered that three-quarters of patients with idiopathic...
by Lee Han-soo
|
2019-03-14 17:43
라인
Loss-making Medipost seeks to avoid administrative issue designation
Medipost, a company specializing in stem cell research, is drawing the indu...
by Jeong Sae-im
|
2019-03-14 14:33
라인
KIMES 2019 opens 4-day show in Seoul
The Korea International Medical & Hospital Equipment Show (KIMES) 2019 kick...
by Lee Han-soo
|
2019-03-14 14:19
라인
Key to successful dental implants for diabetic patients found
Korean researchers said they have discovered a way to help diabetic patient...
by Lee Hye-seon
|
2019-03-14 11:18
라인
Pharmbio Korea to develop antifungal drug with BioSynectics’ nanotechnology
Pharmbio Korea said Wednesday that it has signed a licensing-in deal with B...
by Lee Han-soo
|
2019-03-13 17:48
라인
YD Life Science to distribute Fresenius Kabi’s cell-processing system
YD Life Science said Wednesday that it has signed an agreement with Freseni...
by Lee Han-soo
|
2019-03-13 16:35
라인
Daewoong to enter P3 trial for Nabota in China
Daewoong Pharmaceutical said Wednesday that the China Food and Drug Adminis...
by Lee Han-soo
|
2019-03-13 15:43
라인
WHO regional director impressed by Korea’s health insurance review system
Takeshi Kasai, new regional director of the World Health Organization Weste...
by Song Soo-youn
|
2019-03-13 14:50
라인
Science ministry to launch medical AI service in December
The Ministry of Science and ICT said it would begin providing a trial servi...
by Kwak Sung-sun
|
2019-03-13 13:37
라인
Regulator OKs Yuyu’s P2 clinical trial into dry eye treatment
Yuyu Pharmaceutical said Wednesday that the Ministry of Food and Drug Safet...
by Lee Han-soo
|
2019-03-13 12:43
라인
Tecentriq becomes 1st immunotherapy OKed for specific breast cancer
Roche said its PD-L1 (programmed death-ligand 1) inhibitor Tecentriq (ingre...
by Kim Yun-mi
|
2019-03-13 12:43
라인
GemVax & KAEL completes patient enrollment for P2 clinical trial into GV1001
GemVax & KAEL said Wednesday that it has completed patient registration for...
by Lee Han-soo
|
2019-03-13 10:49
라인
Dong-A ST’s erectile dysfunction treatment improves postmicturition dribbling
Dong-A ST said Monday that it has confirmed that Zydena (ingredient: Udenaf...
by Lee Han-soo
|
2019-03-12 18:02
라인
ImmuneOncia ends P1 clinical trials for solid cancer treatment
ImmuneOncia Therapeutics, a subsidiary of Yuhan Corp., said Tuesday that it...
by Lee Han-soo
|
2019-03-12 17:46
라인
Drugmakers to name new CEOs, enhance ownership
The pharmaceutical industry is expected to witness significant changes in m...
by Jeong Sae-im
|
2019-03-12 16:17
라인
EU Gateway Healthcare exhibit opens for 2-day run in Seoul
EU Gateway to Korea kicked off its annual “EU Gateway Healthcare & Medical ...
by Lee Han-soo
|
2019-03-12 15:59
라인
Regulator OKs Humedix’s osteoarthritis treatment
Humedix said Monday that it has received sales approval for Humia, an osteo...
by Lee Han-soo
|
2019-03-12 13:55
-
이전
141
142
143
144
145
146
147
148
149
150
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top